Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Centralized Pregnancy Registries May Benefit Small Firms Most - FDA

Executive Summary

A centralized pregnancy registry may be most beneficial for smaller pharmaceutical and biotech companies by addressing resource and infrastructure limitations, FDA suggested at a March 29 meeting of the Pregnancy Labeling Subcommittee.

You may also be interested in...



Pregnancy Safety Reporting Reg Will Add Additional Data To Product Labels

Manufacturers will need to work with FDA to incorporate information on drug experience during pregnancy into product labeling, following publication of an upcoming safety reporting regulation from the agency, Office of Drug Evaluation IV Deputy Director Sandra Kweder, MD, said Dec. 4.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel